Cargando…

Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study

BACKGROUND: Secondary hyperparathyroidism (SHPT) is associated with mortality in patients with chronic kidney disease (CKD), but the economic consequences of SHPT have not been adequately studied in the European population. We assessed the relationship between SHPT parameters (intact parathyroid hor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiroli, Silvia, Mattin, Caroline, Belozeroff, Vasily, Perrault, Louise, Mitchell, Dominic, Gioni, Ioanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504570/ https://www.ncbi.nlm.nih.gov/pubmed/23106934 http://dx.doi.org/10.1186/1471-2369-13-140

Ejemplares similares

Healthcare use and costs before and after parathyroidectomy in patients on dialysis
por: Belozeroff, Vasily, et al.
Publicado: (2013)

Emergency Response to Natural Disasters: The Experience of Fresenius Medical Care
por: Sawin, Dixie-Ann, et al.
Publicado: (2023)

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis
por: Natoli, Jaime L, et al.
Publicado: (2013)

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events
por: Hardtstock, Fränce, et al.
Publicado: (2021)

ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation
por: Sebti, Maria, et al.
Publicado: (2022)

Characteristics of Intracranial Aneurysms in the Else Kröner-Fresenius Registry of Autosomal Dominant Polycystic Kidney Disease
por: Neumann, Hartmut P.H., et al.
Publicado: (2012)

Antipyretic potential of dichloromethane leaf extract of Eucalyptus globulus (Labill) and Senna didymobotrya (Fresenius) in rats models
por: Mworia, Joseph Kiambi, et al.
Publicado: (2019)

Anti-inflammatory potential of dichloromethane leaf extracts of Eucalyptus globulus (Labill) and Senna didymobotrya (Fresenius) in mice
por: Mworia, Joseph Kiambi, et al.
Publicado: (2021)

Production and partial characterization of serine and metallo peptidases secreted by Aspergillus fumigatus Fresenius in submerged and solid state fermentation
por: da Silva, Ronivaldo Rodrigues, et al.
Publicado: (2013)

Description of two new Drepanomonas taxa and an account on features defining species in Drepanomonas Fresenius, 1858 (Ciliophora, Microthoracida)
por: Omar, Atef, et al.
Publicado: (2013)

Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation
por: Oostenbrink, Lisa V. E., et al.
Publicado: (2019)

Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Song, Turun, et al.
Publicado: (2020)

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis
por: Davies, Evan W., et al.
Publicado: (2015)

Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease
por: Briggs, Andrew H., et al.
Publicado: (2019)

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme
por: Wang, Lu, et al.
Publicado: (2023)

Mineral Resource Governance in the 21st Century and a sustainable European Union
por: Christmann, Patrice
Publicado: (2021)

Low-Cost, Accessible Fabrication Methods for Microfluidics Research in Low-Resource Settings
por: Nguyen, Hoang-Tuan, et al.
Publicado: (2018)

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
por: Canbay, Ali, et al.
Publicado: (2021)

Quantification of Recyclable Peritoneal Dialysis Plastics in a Home Dialysis Program–An Opportunity for Resource Stewardship
por: Rao, Nisha, et al.
Publicado: (2022)

Development and validation of a predictive mortality risk score from a European hemodialysis cohort
por: Floege, Jürgen, et al.
Publicado: (2015)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

Mineral Metabolic Abnormalities and Mortality in Dialysis Patients
por: Abe, Masanori, et al.
Publicado: (2013)

Review of Statistical Methods for Analysing Healthcare Resources and Costs
por: Mihaylova, Borislava, et al.
Publicado: (2011)

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
por: Ronco, Raffaella, et al.
Publicado: (2023)

Petroleum and mineral resources /
Publicado: (2013)

Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders
por: Truyts, César, et al.
Publicado: (2021)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Berrada, Myriam, et al.
Publicado: (2021)

Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism
por: McHorney, Colleen A., et al.
Publicado: (2018)

Obesity-related complications, healthcare resource use and weight loss strategies in six European countries: the RESOURCE survey
por: Evans, Marc, et al.
Publicado: (2023)

Rethinking the cost of healthcare in low-resource settings: the value of time-driven activity-based costing
por: McBain, Ryan K, et al.
Publicado: (2016)

Rational allocation of resources available for healthcare: understanding cost effectiveness analyst
por: Briggs, Andrew
Publicado: (2014)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2023)

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience
por: Zhou, Ling, et al.
Publicado: (2020)

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries
por: Body, Jean-Jacques, et al.
Publicado: (2016)

Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs
por: Espín, Jaime, et al.
Publicado: (2022)

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study
por: Kiiskinen, Urpo, et al.
Publicado: (2013)

Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study
por: Zhan, Zhipeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b9ajbrmdnkqgstioilj7g7bjsg